ABSTRACT
Recent studies in machine learning have demonstrated the effectiveness of applying graph neural networks (GNNs) to single-cell RNA sequencing (scRNA-seq) data to predict COVID-19 disease states. In this study, we propose a graph attention capsule network (GACapNet) which extracts and fuses Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) transcriptomic patterns to improve node classification performance on cells and genes. Significantly different from the existing GNN approaches, we innovatively incorporate a capsule layer with dynamic routing into our model architecture to combine and fuse gene features effectively and to allow those more prominent gene features present in the output. We evaluate our GACapNet model on two scRNA-seq datasets, and the experimental results show that our GACapNet model significantly outperforms state-of-the-art baseline models. Therefore, our study demonstrates the capability of advanced machine learning models to generate predictive features and evolutionary patterns of the SARS-CoV-2 pathogen, and the applicability of closing knowledge gaps in the pathogenesis and recovery of COVID-19. © 2022 IEEE.
ABSTRACT
At present, severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still rampant worldwide.As of September 10, 2021, there were about 222 million confirmed cases of corona virus disease 2019(COVID-19)and more than 4.6 million deaths worldwide.With the development of COVID-19 vaccines and the gradual vaccination worldwide, the increasing number of cases in children and unvaccinated young people has drawn attention.According to World Health Organization surveillance data, the proportion of COVID-19 infection cases in children gradually increased, and the proportion of cases in the age groups of under 5 years and 5-14 years increased from 1.0% and 2.5% in January 2020 to 2.0% and 8.7% in July 2021, respectively.At present, billions of adults have been vaccinated with various COVID-19 vaccines worldwide, and their protective effects including reducing infection and transmission, reducing severe disease and hospitalization, and reducing death, as well as high safety have been confirmed.Canada, the United States, Europe and other countries have approved the emergency COVID-19 vaccination in children and adolescents aged 12 to 17 years, and China has also approved the phased vaccination of COVID-19 vaccination in children and adolescents aged 3 to 17 years. For smooth advancement and implementation of COVID-19 vaccination in children, academic institutions, including National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, and The Society of Pediatrics, Chinese Medical Association organized relevant experts to reach this consensus on COVID-19 vaccination in children.Copyright © 2021 by the Chinese Medical Association.
ABSTRACT
Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection is still worldwide.As a vulnerable group, severe and dead pediatric cases are also reported.Under this severe epidemic situation, children should be well protected.With the widespread vaccination of SARS-CoV-2 vaccine in adults, the infection rate have decreased.Therefore, SARS-CoV-2 vaccine inoculation for children groups step by step is of great significance to the protection of children and the prevention and control of corona virus disease 2019(COVID-19) as a whole.But the safety of children vaccinated with SARS-CoV-2 vaccine is a main concern of parents.Therefore, in order to ensure the safety of vaccination and the implementation of vaccination work, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health and the Society of Pediatrics, Chinese Medical Association organized experts to interpret the main issue of parents about SARS-CoV-2 vaccine for children, in order to answer the doubts of parents.Copyright © 2021 by the Chinese Medical Association.
ABSTRACT
COVID-19 has obvious family clustering, and clustering refers to the occurrence of 2 or more confirmed es or asymptomatic infection in a small area within 14 days [1]. The clinical manifestations of familial clustering COVID-19 are related to exposure time, exposure degree, virus type, virus virulence, and patient age [2], which are mostly manifested as fever, chills, fatigue, ocional diarrhea, sore throat, or asymptomatic [3]. Symptoms are mild in children, and more severe in elderly or patients with chronic underlying diseases [4]. If there is an infected person in the family, it is easy to cause mutual infection;chest CT is helpful for the screening of suspected family es, early diagnosis, early treatment, and early isolation. The CT findings of the family cluster COVID-19 es are consistent with the typical manifestations of COVID-19. In the same group of family es, the lesion density and degree are similar [5]. The number of lesions and the range of involvement of multi-generation infected persons are reduced compared with earlier generations. The chest CT of children may be negative, and the lung lesions of the elderly or patients with chronic underlying diseases may be more severe. In the follow-up after treatment, the vast majority of the lung lesions were absorbed to different degrees, and the residual shadows were mostly ground-glass opacities or fibrous shadows. The chest CT findings of most patients could finally return to normal. © Henan Science and Technology Press 2020.
ABSTRACT
The pandemic of coronavirus disease 2019 is "not over,"in fact, the "dynamic clearing"policy for SARS-CoV-2 control and prevention in China has been firmly enforced. This study aimed to analyze the clinical symptoms and dynamic viral RNA changes in 2021 at Guangzhou Eighth People's Hospital. This study showed that 31.4% of the patients (695/2212) tested negative for viral RNA from admission to the final release from quarantine. Of all negative cases, 86.5% (601/695) remained in the hospital for no more than 5 days and were asymptomatic or mild. Among the remaining 402 patients who stayed for no more than 5 days, 76.4% (307/402) were viral RNA retest positive during the isolation stage. However, 96.4% of the peak viral RNA (296/307) was over Ct = 33 cycles during the isolation stage. © Wolters Kluwer Health, Inc. All rights reserved.
ABSTRACT
Backgroud: The outbreak of COVID-19 has brought unprecedented perils to human health and raised public health concerns in more than two hundred countries. Safe and effective treatment scheme is needed urgently. Objective(s): To evaluate the effects of integratedTCM and western medicine treatment scheme on COVID-19. Method(s): A single-armed clinical trial was carried out in Hangzhou Xixi Hospital, an affiliated hospital with Zhejiang Chinese Medical University. 102 confirmed cases were screened out from 725 suspected cases and 93 of them were treated with integrated TCM and western medicine treatment scheme. Result(s): 83 cases were cured, 5 cases deteriorated, and 5 cases withdrew from the study. No deaths were reported. The mean relief time of fever, cough, diarrhea, and fatigue were (4.78 +/- 4.61) days, (7.22 +/- 4.99) days, (5.28 +/- 3.39) days, and (5.28 +/- 3.39) days, respectively. It took (14.84 +/- 5.50) days for SARS-CoV-2 by nucleic acid amplification-based testing to turn negative. Multivariable cox regression analysis revealed that age, BMI, PISCT, BPC, AST, CK, BS, and UPRO were independent risk factors for COVID-19 treatment. Conclusion(s): Our study suggested that integrated TCM and western medicine treatment scheme was effective for COVID-19.Copyright © 2021
ABSTRACT
2019 novel coronavirus(2019-nCoV) outbreak is one of the public health emergency of international concern.Since the 2019-nCoV outbreak, China has been adopting strict prevention and control measures, and has achieved remarkable results in the initial stage of prevention and control.However, some imported cases and sporadic regional cases have been found, and even short-term regional epidemics have occurred, indicating that the preventing and control against the epidemic remains grim.With the change of the incidence proportion and the number of cases in children under 18 years old, some new special symptoms and complications have appeared in children patients.In addition, with the occurrence of virus mutation, it has not only attracted attention from all parties, but also proposed a new topic for the prevention and treatment of 2019-nCoV infection in children of China.Based on the second edition, the present consensus further summarizes the clinical characteristics and experience of children's cases, and puts forward recommendations on the diagnostic criteria, laboratory examination, treatment, prevention and control of children's cases for providing reference for further guidance of treatment of 2019-nCoV infection in children.Copyright © 2021 Chinese Medical Association
ABSTRACT
In 2020, the COVID-19 epidemic broke out and since then civil engineering systems all over the world have been deeply influenced. The epidemic prevention policies directly made most of conventional works not feasible and new ways of working for civil system are needed like telecommuting and other remote technologies. In this paper, the approaches of system engineering are used to divide normal civil engineering system into many phases from the perspective of civil system development and list impact of the COVID-19 epidemic on each phase. The system analysis make us have a more comprehensive understanding of the problem in civil system and make it possible to optimize a specific phase in more targeted way. Moreover, in this way, we can not only comprehend the characteristics of every phase, but also clarify the relationships between them. © 2023, The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
ABSTRACT
The prevalence of porcine enteric coronaviruses (PECs), including transmissible gastroenteritis virus (TGEV), swine acute diarrhea syndrome coronavirus (SADS-CoV), porcine delta coronavirus (PDCoV), and porcine epidemic diarrhea virus (PEDV), poses a serious threat to animal and public health. Here, we aimed to further optimize the porcine aminopeptidase N (pAPN) gene editing strategy to explore the balance between individual antiviral properties and the biological functions of pAPN in pigs. Finally, APN-chimeric gene-edited pigs were produced through a CRISPR/Cas9-mediated knock-in strategy. Further reproductive tests indicated that these gene-edited pigs exhibited normal pregnancy rates and viability. Notably, in vitro viral challenge assays further demonstrated that porcine kidney epithelial cells isolated from F1-generation gene-edited pigs could effectively inhibit TGEV infection. This study is the first to report the generation of APN-chimeric pigs, which may provide a natural host animal for characterizing PEC infection with APN and help in the development of better antiviral solutions. © 2022 Elsevier B.V.
ABSTRACT
Severe acute respiratory syndrome coronavirus-2 infection is usually self-limited, with a short duration for viral shedding within several weeks. However, prolonged viral shedding has been observed in severe or immune-compromised coronavirus disease 2019 (COVID-19) cases. Here, we reported that three young adult cases of COVID-19 patients, who were either immunosuppressed nor severe, showed prolonged viral RNA shedding from the upper respiratory tract for 58, 81, and 137 days since initial diagnosis. To our knowledge, this is the longest duration of viral shedding reported to date in young adult patients. Further studies on factors relevant to prolonged viral positivity, as well as the correlation between viral positivity and transmission risk are needed for the optimal management of COVID-19 patients with prolonged nucleic acid positive. © Copyright 2022 The Chinese Medical Association, published by Wolters Kluwer Health, Inc.
ABSTRACT
During the COVID-19 pandemic, the current operating environment of pharmaceutical supply chain (PSC) has rapidly changed and faced increasing risks of disruption. The Internet of Things (IoT) and blockchain not only help enhance the efficiency of PSC operations in the information technology domain but also address complex related issues and improve the visibility, flexibility, and transparency of these operations. Although IoT and blockchain have been widely examined in the areas of supply chain and logistics management, further work on PSC is expected by the public to enhance its resilience. To respond to this call, this paper combines a literature review with semi-structured interviews to investigate the characteristics of PSC, the key aspects affecting PSC, and the challenges faced by PSC in the post-pandemic era. An IoT-blockchain-integrated hospital-side oriented PSC management model is also developed. This paper highlights how IoT and blockchain technology can enhance supply chain resilience and provides a reference on how PSC members can cope with the associated risks.
ABSTRACT
Outdoor fresh air ventilation plays a significant role in reducing airborne transmission of diseases in indoor spaces. School classrooms are considerably challenged during the COVID-19 pandemic because of the increasing need for in-person education, untimely and incompleted vaccinations, high occupancy density, and uncertain ventilation conditions. Many schools started to use CO2 meters to indicate air quality, but how to interpret the data remains unclear. Many uncertainties are also involved, including manual readings, student numbers and schedules, uncertain CO2 generation rates, and variable indoor and ambient conditions. This study proposed a Bayesian inference approach with sensitivity analysis to understand CO2 readings in four primary schools by identifying uncertainties and calibrating key parameters. The outdoor ventilation rate, CO2 generation rate, and occupancy level were identified as the top sensitive parameters for indoor CO2 levels. The occupancy schedule becomes critical when the CO2 data are limited, whereas a 15-min measurement interval could capture dynamic CO2 profiles well even without the occupancy information. Hourly CO2 recording should be avoided because it failed to capture peak values and overestimated the ventilation rates. For the four primary school rooms, the calibrated ventilation rate with a 95% confidence level for fall condition is 1.96+/-0.31 ACH for Room #1 (165 m3 and 20 occupancies) with mechanical ventilation, and for the rest of the naturally ventilated rooms, it is 0.40+/-0.08 ACH for Room #2 (236 m3 and 21 occupancies), 0.30+/-0.04 or 0.79+/-0.06 ACH depending on occupancy schedules for Room #3 (236 m3 and 19 occupancies), 0.40+/-0.32,0.48+/-0.37,0.72+/-0.39 ACH for Room #4 (231 m3 and 8-9 occupancies) for three consecutive days.
ABSTRACT
The present study explored the inflammatory response and clinical efficacy of Tanreqing injection in combination with antiviral therapy in patients with coronavirus disease (COVID-19). The results demonstrated that the levels of C-reactive protein (CRP) and interleukin-6 (IL-6) in the treatment group were significantly lower than those in the control group (p < 0.05). Clinical efficacy assessment revealed a significant improvement in the time necessary for image absorption improvement in the treatment group (p < 0.05), while the time taken for fever and muscle soreness symptoms to resolve significantly reduced (p < 0.05). Furthermore, the time taken to obtain a negative COVID-19 test result was significantly shortened (p < 0.05). Tanreqing injection combined with antiviral treatment improved clinical symptoms of COVID-19 faster than when the anti-viral treatments were used alone and this may be related to the reduction in inflammatory response. Copyright © 2022, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
ABSTRACT
The outbreak of the COVID-19 pandemic at the end of 2019 has caused a profound impact on economic development. The catering, logistics and tourism industries have suffered a huge blow. This paper selects the catering industry as the research object, selects the 2019 and 2020 annual reports of five representative listed catering companies, classifies and summarizes the stated criteria for determination of the occurrence of self-interest attribution, calculates the degree of self-interest attribution, and compares and analyzes whether the self-interest attribution behavior of the five case companies before and after the COVID-19 pandemic stands out or amplifies the self-interest attribution behavior of the companies. The case studies showed that the degree of self-interest attribution was higher in the poor-performing companies, and that the impact of the COVID-19 pandemic on the self-interest behavior of restaurant companies was prominent, and that the poor external environment was more likely to lead to a higher degree of self-interest attribution behavior. © 2022 IEEE.
ABSTRACT
Background: Patients with SARS-CoV-2 with a diagnosis of cancer have increased risk of severe COVID-19 outcomes compared to patients without cancer. However, little is known regarding outcomes of patients with COVID-19 and cancer in the setting of human immunodeficiency virus (HIV). Given the unique risks of this population, we sought to understand COVID-19 outcomes using registry data. Methods: This is a descriptive research study utilizing the CCC19 registry, an international multi-institutional registry with healthcare provider-reported cases of patients with cancer and COVID-19. Between March 2020-December 2021, 116 persons with HIV (PWH) and 10,642 persons without HIV (PWOH) with laboratory-confirmed SARS-CoV-2 infection were identified as eligible for the analysis. Results: Median follow-up time for both groups was 90 days, with interquartile range (IQR) 30-180 days. Most PWH were actively receiving antiretroviral therapy (ART) at the time of COVID-19 diagnosis, with 71% (n = 82) having named drug information available;bictegravir/emtricitabine/tenofovir was the most common ART (n = 25). PWH were of younger age (median 57.5 yrs [IQR 46.5-63.25] vs 65 yrs [IQR 55-74]), male (81% vs 47%), and either non-Hispanic Black or Hispanic (71% vs 34%) compared to PWOH. 12% of PWH (n = 14) were current smokers compared to 6% of PWOH (n = 638), and more than half in each group were never smokers (51% of PWH and 53% of PWOH). The following comorbidities were identified in PWH vs PWOH: cardiovascular (16% vs 20%), pulmonary (16% vs 20%), renal (15% vs 14%), and diabetes mellitus (18% vs 27%). A higher proportion of PWH had hematologic malignancy compared to PWOH (33% vs 19%). More PWH had active cancer which was progressing at the time of SARS-CoV-2 infection compared to PWOH (24% vs 14%). 44% of PWH (n = 51) had received active systemic anticancer therapy within the 3 months preceding SARS-CoV-2 infection (including cytotoxic, targeted, endocrine therapies, and immunotherapy) compared to 51% of PWOH (n = 5,420). PWH had an increased rate of hospitalization (58% vs 55%) compared to PWOH. Although a lower proportion of PWH required supplemental oxygen during hospitalization compared to PWOH (34% vs 38%) and ICU admission rates were identical between the two groups (16% vs 16%), PWH had an increased rate of mechanical ventilation (14% vs 10%) and death (24% vs 18%) compared to PWOH. Conclusions: This is the first known study describing outcomes of patients with cancer and COVID-19 in the PWH population from a large multinational dataset. PWH have characteristics associated with adverse outcomes in prior analyses (male sex, non-Hispanic Black or Hispanic, hematologic malignancy, progressing cancer) but are notably younger and have fewer comorbidities. HIV infection may portend increased risk of severe COVID-19 and death;however, additional analyses, including multivariable regression, are warranted.
ABSTRACT
SARS-CoV-2 variants have shown increased transmission capabilities and pandemic to an extent with severe presentation and mortality. The delta variant has been declared as an emerging variant of concern (VOC) by the World Health Organization (WHO) on May 10, 2021. This review summarizes the post-vaccination infection events related to SARS-CoV-2 delta variant outbreaks in many areas of China. The characteristics and measures of delta variant-induced COVID-19 infections from May 2021 to October 2021 were reported. We compared the delta variant with the omicron from the latest literature review.